Detalhe da pesquisa
1.
Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15.
Cancer Immunol Immunother
; 70(9): 2701-2719, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244816
2.
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment.
Nanomedicine
; 17: 71-81, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654182
3.
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.
Br J Cancer
; 119(9): 1086-1093, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361524
4.
HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer.
BMC Cancer
; 16: 352, 2016 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27259714
5.
A gradient-loadable (64)Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography.
Nanomedicine
; 11(1): 155-65, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25200610
6.
Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients.
Am J Pathol
; 183(5): 1446-1460, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24035511
7.
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes.
JCI Insight
; 9(6)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516892
8.
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity.
Toxicol Appl Pharmacol
; 262(1): 1-10, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22676972
9.
The Single Match: Reflections on the National Resident Matching Program's Sustained Partnership With Learners.
Acad Med
; 96(8): 1116-1119, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913441
10.
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.
Nat Commun
; 12(1): 2637, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33976146
11.
Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
J Clin Invest
; 115(5): 1281-9, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15841217
12.
Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines.
Theranostics
; 8(9): 2300-2312, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721081
13.
Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.
Int J Oncol
; 31(4): 813-22, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17786312
14.
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.
Clin Cancer Res
; 23(15): 4190-4202, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28298546
15.
Ligand-directed targeting of genes to the site of disease.
Nat Med
; 9(1): 135-9, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12514727
16.
Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer.
Cancer Res
; 76(6): 1517-27, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26759238
17.
Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates.
EJNMMI Res
; 5: 24, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918676
18.
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302).
Mol Cancer Ther
; 14(9): 2060-71, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26162690
19.
The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors.
Hum Gene Ther
; 14(7): 627-43, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12804145
20.
Binding of adenoviral fiber knob to the coxsackievirus-adenovirus receptor is crucial for transduction of fetal muscle.
Hum Gene Ther
; 14(7): 645-9, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12804146